期刊文献+

联合应用生长激素和生长抑素对乳腺癌移植瘤的治疗作用 被引量:5

EFFECT OF GROWTH HORMONE AND SOMATOSTATIN ON BREAST CARCINOMA IMPLANTED IN NUDE MICE
下载PDF
导出
摘要 目的:探讨联合应用生长激素(growth hormone,GH)和生长抑素(Somatostatin,SST)在乳腺癌移植瘤动物模型治疗中的作用及影响。方法:通过乳腺癌细胞培养,将乳腺癌MCF-7细胞注射入40只裸鼠的右腋窝皮下,建立乳腺癌移植瘤动物模型,将其随机分成生理盐水组(NS组)、GH组、SST组、GH+SST组4组,每组10只,给予GH和SST治疗后,观察裸鼠的体重变化、移植瘤体积变化。裸鼠处死后剥取移植瘤称重,计算肿瘤抑瘤率,行瘤体切片病理检查和免疫组化指标Ki-67、Bcl-2检查,以检测肿瘤细胞的增殖和凋亡,并对实验组与对照组进行比较。结果:①裸鼠注射药物前后体积变化与对照组比较,差异有统计学意义(P<0.05)。②治疗前后裸鼠移植瘤体积变化与对照组比较:GH组差异无统计学意义(P>0.05),SST组和GH+SST组差异有统计学意义(P<0.05)。③治疗后裸鼠移植瘤重量和抑瘤率与对照组比较:GH组移植瘤重量差异无统计学意义(P>0.05),SST组和GH+SST组差异有统计学意义(P<0.05)。抑瘤率GH组为18.47%,SST组为48.55%,GH+SST组为30.32%。④移植瘤常规病理和免疫组化检查结果与对照组比较:镜下观察各组移植瘤瘤体瘤组织间有较多粗细不一的纤维组织将瘤组织分隔成巢状,偶见围成腺腔,均可见片状坏死灶,SST组坏死灶增大。Ki-67标记指数和Bcl-2表达与对照组比较:GH组差异无统计学意义(P>0.05)。SST组和GH+SST组差异有统计学意义(P<0.05)。结论:①GH促进裸鼠体重增加但并不促进肿瘤生长;②SST抑制肿瘤生长;③GH和SST联用可改善裸鼠营养状况,抑制肿瘤生长,该研究结果为临床应用GH和SST治疗乳腺癌提供了科学依据。 Objective:To investigate the effect of growth hormone (GH) and somatostatin (SST) on breast carcinoma implanted in nude mice. Methods:MCF-7 cells were implanted into the right axillary fossa's subcutaneous tissue in 40 nude mice. After the model of breast carcinoma was established, the animals were randomly divided into 4 groups: GH, SST, GH+SST and control groups, with 10 mice in each group. Tumor growth was observed. After these were administered, all mice were killed. The weight of the transplantation tumor was measured. The structure of the tumor was observed with microscope and the expression levels of Ki-67 and Bcl-2 which detect the proliferation and apoptosis of tumor cells were examined by immunohistoehemistry. Then we compared the results between treated groups and control group. Results: (1)The change of valume in nude mice: Among all groups, the difference was significant( P〈0.05). (2)The volume change of transplantation tumor in nude mice after administration: the difference of control group and SST group was significant( P 〈0.05), the same as that of control group and GH+SST group. (3)The weight of transplantation tumor and tumor inhibition rate in nude mice after administration: the difference of control group and SST group was significant( P 〈0.05), the same as that of control group and GH+ SST group. The tumor inhibition rate were 18.47%, 48.55% and 30.32% in GH group, SST group, GH+SST group. (4)The result of pathological section and immunohistochemical staining of transplantation tumor: the difference of control group and SST groupin Ki-67 and Bcl-2 was significant( P d0.05), the same as that of control group and GHq-SST group. Con- clusion.GH can increase the weight of nude mice, but can not hasten the tumor's proliferation. SST inhibits the growth of tumor. Combined GH with SST can change the nude mice's nutritional status, and inhibit the growth of tumor. The study provides scientific basis for the treatment of breast cancer with GH and SST in clinic.
出处 《广西医科大学学报》 CAS 2010年第3期329-332,共4页 Journal of Guangxi Medical University
基金 广西自然科学基金资助项目(No.桂科自0640110)
关键词 乳腺癌 生长激素 生长抑素 移植瘤 breast neoplasm growth hormone somatostatin transplantation tumor
  • 相关文献

参考文献10

  • 1Svendsen AL,Olsen AH,von Euler-Chelpin M,et al.Breast cancer incidence after the introduction of mammography screening:what should be expected?[J].Cancer,2006,106:1 883-1 890.
  • 2廖清华,吴向华,陆云飞,林坚,曾健,蔡小勇.重组人生长激素对人乳腺癌细胞株MCF-7细胞周期作用的实验研究[J].广西医科大学学报,2004,21(2):195-196. 被引量:1
  • 3郭祖超.医用数理统计方法[M].3版.北京:人民卫生出版社,1988:843-857.
  • 4Jian-mei Hou,Ji-yan Liu,Li Yang,et al.Combination of Low-Dose Gemcitabine and Recombinant Quail Vascular Endothelial Growth Factor Receptor-2 as a Vaccine Induces Synergistic Antitumor Activities[J].Oncology,2005,69:81-87.
  • 5Laban C,Bustin SA,Jenkins PJ.The GH-IGF-I axis and breast cancer[J].Trends Endocrinol Metab,2003,14:28-34.
  • 6Torosian MH,Donoway RB.Growth hormone inhibits tumors metastasis[J].Cancer,1991,67:2 280-2 283.
  • 7Wennbo H,Gebre-Medhin M,Gritli-Linde A,et al.Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice[J].Clin Invest,1997,100:2 744-2 751.
  • 8Dasgupta P.Somatostatin analogues:Multiple roles in cellular proliferation,neoplasia,and angiogenesis[J].Pharmacol Ther,2004,102:61-85.
  • 9Bryant RJ,Banks PM,O'Malley DP.Ki-67 staining pattern as a diagnostic tool in the evaluation of lymphoproliferative disorders[J].Histopathology,2006,48:505-515.
  • 10黎介寿,任建安,王新波,顾军,姜军.生长抑素与生长激素促进肠外瘘自愈的机理与临床研究[J].中华外科杂志,2000,38(6):447-450. 被引量:167

二级参考文献10

  • 1黎介寿,韩建明,顾寿年,李宁,尹路.肠外瘘661例临床分析[J].普外临床,1994,9(3):171-174. 被引量:64
  • 2黎介寿,普外临床,1994年,9期,171页
  • 3Charlotte G,David WG.Hormonal effects on cell prolife-ration in human erythroleukemia cell line (K562).Blood,1980,56(5):886-891.
  • 4Akaza H,Matsukik,Matsushiam H,et al.Stimulatory ef-fects of growth hormone on rat bladder carcinogenesis.Cancer,1991,68(11):2 418-2 421.
  • 5Michael HT,Robert BD.Growth hormone inhibits tumor metastasis.Cancer,1991,67(9):2 280-2 283.
  • 6Ogawa M,Osamu M,Kamijo T,et al.The occurrence of acute lymphoblastic leukemia shorly after the cessation of humam growth hormone therapy.Jpn J Clin Oncol,1988,(18):255-260.
  • 7Nishi Y,Tanaka T,Takanok,et al.Recent status iu the occurrence of Leukemia in grouth hormone-treated paitients in Japan.J Clin Endocrinol Meteb,1999,84:1 961-1 965.
  • 8Tacke J,Boler U,Herrmann A,et al.Long-term risk of gastrointes tinal tumor recurrence after post operative treatment with recombinant human growth hormone.J Patent Enter Nutri,2000,24(3):140-144.
  • 9Sweralow AJ,Reddingias RE,Higgins CD,et al.Growth hormone treatment of childen with brain tumors and risk of tumor recurrence.J Clin Endocrino Metab,2000,85(12):4 444-4 449.
  • 10Chang TC,Lin JJ,Yu SC,et al.Absence of growth horm-one receptor in hepatic cellular carcinoma and cirrbotic liver.Hepatology,1990,11(1):123.

共引文献171

同被引文献62

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部